| UniProt ID | DYL2_HUMAN | |
|---|---|---|
| UniProt AC | Q96FJ2 | |
| Protein Name | Dynein light chain 2, cytoplasmic | |
| Gene Name | DYNLL2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 89 | |
| Subcellular Localization | Cytoplasm, cytoskeleton. | |
| Protein Description | Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in changing or maintaining the spatial distribution of cytoskeletal structures (By similarity).. | |
| Protein Sequence | MSDRKAVIKNADMSEDMQQDAVDCATQAMEKYNIEKDIAAYIKKEFDKKYNPTWHCIVGRNFGSYVTHETKHFIYFYLGQVAILLFKSG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Acetylation | ---MSDRKAVIKNAD ---CCCHHHHHHCCC | 52.58 | 19608861 | |
| 5 | Ubiquitination | ---MSDRKAVIKNAD ---CCCHHHHHHCCC | 52.58 | 22817900 | |
| 9 | Acetylation | SDRKAVIKNADMSED CCHHHHHHCCCCCHH | 39.21 | 25953088 | |
| 9 | Malonylation | SDRKAVIKNADMSED CCHHHHHHCCCCCHH | 39.21 | 26320211 | |
| 9 | Ubiquitination | SDRKAVIKNADMSED CCHHHHHHCCCCCHH | 39.21 | 22817900 | |
| 14 | Phosphorylation | VIKNADMSEDMQQDA HHHCCCCCHHHHHHH | 30.87 | 28176443 | |
| 26 | Phosphorylation | QDAVDCATQAMEKYN HHHHHHHHHHHHHCC | 24.16 | 28176443 | |
| 31 | Ubiquitination | CATQAMEKYNIEKDI HHHHHHHHCCCHHHH | 30.43 | 23000965 | |
| 31 | Acetylation | CATQAMEKYNIEKDI HHHHHHHHCCCHHHH | 30.43 | 25038526 | |
| 32 | Phosphorylation | ATQAMEKYNIEKDIA HHHHHHHCCCHHHHH | 14.20 | 28152594 | |
| 36 | Acetylation | MEKYNIEKDIAAYIK HHHCCCHHHHHHHHH | 51.11 | 23954790 | |
| 36 | Ubiquitination | MEKYNIEKDIAAYIK HHHCCCHHHHHHHHH | 51.11 | 23000965 | |
| 41 | Phosphorylation | IEKDIAAYIKKEFDK CHHHHHHHHHHHHHC | 12.30 | 28152594 | |
| 43 | Ubiquitination | KDIAAYIKKEFDKKY HHHHHHHHHHHHCCC | 33.31 | 23000965 | |
| 44 | Ubiquitination | DIAAYIKKEFDKKYN HHHHHHHHHHHCCCC | 54.80 | 23000965 | |
| 48 | Ubiquitination | YIKKEFDKKYNPTWH HHHHHHHCCCCCCCE | 63.58 | 23000965 | |
| 49 | Ubiquitination | IKKEFDKKYNPTWHC HHHHHHCCCCCCCEE | 52.70 | 23000965 | |
| 49 | Sumoylation | IKKEFDKKYNPTWHC HHHHHHCCCCCCCEE | 52.70 | - | |
| 49 | Sumoylation | IKKEFDKKYNPTWHC HHHHHHCCCCCCCEE | 52.70 | - | |
| 49 | Methylation | IKKEFDKKYNPTWHC HHHHHHCCCCCCCEE | 52.70 | - | |
| 50 | Phosphorylation | KKEFDKKYNPTWHCI HHHHHCCCCCCCEEE | 31.92 | 28152594 | |
| 53 | Phosphorylation | FDKKYNPTWHCIVGR HHCCCCCCCEEEECC | 24.97 | 28857561 | |
| 64 | Phosphorylation | IVGRNFGSYVTHETK EECCCCHHHCCCCHH | 16.58 | 28152594 | |
| 65 | Phosphorylation | VGRNFGSYVTHETKH ECCCCHHHCCCCHHH | 15.11 | 25159151 | |
| 67 | Phosphorylation | RNFGSYVTHETKHFI CCCHHHCCCCHHHHH | 13.03 | 25884760 | |
| 70 | Phosphorylation | GSYVTHETKHFIYFY HHHCCCCHHHHHHEE | 23.39 | 23186163 | |
| 88 | Phosphorylation | VAILLFKSG------ HHHHHHHCC------ | 42.26 | 28112733 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DYL2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DYL2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DYL2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5, AND MASS SPECTROMETRY. | |